echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Mylan and Puqiang merge after the new first exposure! What are the meanings? Pfizer, BMS, Teva...

    Mylan and Puqiang merge after the new first exposure! What are the meanings? Pfizer, BMS, Teva...

    • Last Update: 2020-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "The name Viatris conveys the traditional strength sympathies that our two companies share and our shared goal of delivering high-quality medicines to as many patients as possible," said Michael Goettler, President of Upjohn Group, who will serve as CEO of Viatris, which is known to be based in Latin, said in an announcement that it reflects the new company's goal of providing a path from "VIA" to three core "TRIS" goals: to expand drug accessibility, innovate to meet patient needs, and become a trusted partner in the global healthcare sectormany multinational pharmaceutical companies have a unique and a little "mouth" of the name, such as Bollinger Ingeheim, Baishi Mei Shiguibao and so on, these names can not help but make people wonder about their origin and the story behind, E drug managers today specially counted the names of more than a dozen multinational pharmaceutical companies storyPfizerPfizer was founded by a cousin of German immigrants to the United States, with a cousin named Charles Pfizer (1824-1906) and his cousin Charles Erhart (1821-1891)Pfizer studied chemistry, and Earhart worked in the candy businessAround the early 1840s, they came to the United States together to developIn 1849, Pfizer borrowed $2,500 from his father and partnered with Earhart to set up Charles Pfizer and Coin Manhattan, New YorkOn November 12th Pfizer and Mylan announced that the company, named Viatris, was due to close by 2020Johnson and Johnsonjohnson and johnson have more than 100 years of history in the United StatesIn 1886, Robert Wood Johnson and his two brothers, James Wood Johnson and Edward Mead Johnson, started a new business in the United States, producing sterile surgical dressingsIn 1887, the company was officially registered as Johnson and JohnsonWhen it was founded in 1886, James Wood Johnson, one of the founders of Johnson and Johnson, issued the company's first check to pay a local railroad freighter, whose handwriting was the prototype of Johnson's classic logoJohnson and Johnson is currently the world's largest manufacturing group for health products (pharmaceuticals, medical equipment and consumer goods)Overall sales of Q3 China grew by about 15% in 2019, breaking the $1 billion mark for the first time In the past two years, Johnson and Johnson has been enriching its product lines, and more than 20 new drugs and new adaptation certificates have been approved GlaxoSmithKline (GSK) GlaxoSmithKline (GlaxoSmithKline, GSK) was founded in December 2000 by a merger of GlaxoSmithKline and Smith Kline Beecham GlaxoSmithKline, as a large prescription drug manufacturer, combines its advantages with Scone's over-the-counter drug production, with a more comprehensive coverage in the market In 2002, GlaxoSmithKline (China) Investment Co., Ltd fully completed the business integration and officially announced the establishment, after the 2013 crisis, GSK comprehensively reformed the business model, overhauled the marketing system, continuously strengthened the "academic return", sales performance and pharmaceutical representativeperformance evaluation decoupling; Amgen Amgen began in the mid-1970s, when biotech pioneers were trying to develop genetically modified technologies to discover their commercial value, yet pharmaceutical giants seemed uninterested in the new venture In 1980, a group of venture capital experts and scientists organized a new company and invited Rathman, Abbott's vice president of research and development, to take over as the first head The new venture, then known as Applied Molecular Genetics Inc, is the precursor to Amgen, the world's ninth-largest pharmaceutical giant by market capitalisation Amin officially entered China in 2012 and recently attracted considerable attention for the news that it would buy a 20.5 percent stake in Baiji Shenzhou worth about $2.7 billion (about 19 billion yuan) and establish a global strategic partnership with cancer Merck Sharp and , the predecessor of New Jersey-based Merck Pharmaceuticals, is the u.S subsidiary of Merck, a well-known German chemical company, in 1891 After World War I, it was confiscated by the U.S government as an enemy asset and became an independent American chemical and pharmaceutical company in 1919 In 1953, Merck of the United States merged with Sharp and Dohme Pharmaceuticals Merck of the United States and Merck of Germany have decided that in North America (the United States and Canada), U.S companies in the Name of Merck and the rest of the world, in the name of Merck Sharp and Dohme, or MSD China is a key part of Mersaeast's global growth strategy, with revenues reaching $2.368 billion in the first three quarters of 2019, with Q3 sales reaching $898 million, up 90 percent year-on-year Keytruda has listed in China for three adaptation certificates, with sales of more than 2 billion yuan in the Chinese market for a rolling year (for 12 consecutive months) In the national expansion of the 4 plus 7 band procurement, Moshadon's antihypertensive drug, Losartan, and the asthma drug Monruste sodium particles (Shunerin, Singulair) were shortlisted , the of The Times's BMS, has more than 100 years of history in the United States In 1887, the Americans, William McClaren Bligh and John Rip Myers, founded the drug sales company; in the late 19th century, Edward Robinson Squibb founded a pharmaceutical company named after him; and in 1989 the two companies merged to become the world's second-largest pharmaceutical company Last year, the U.S.-China Shanghai Squibb Pharmaceutical Co., Ltd.'s Fusimpli sodium tablets won the bid in the 4 plus 7 episodes, and bmS's O-drug is now being sold globally, generating revenue of $6.735 billion, second only to K-drug in PD-1 AstraZeneca , which was formed in 1999 by a merger between the former Swedish Astra and the former British company Jellicon, is headquartered in London, UK Sweden's Astra Ltd was founded in 1913 by 400 doctors and pharmacies from S?dert?lje On October 24th AstraZeneca reported its results for the first three quarters of 2019 During the reporting period, AstraZeneca achieved sales of $17.315 billion in product sales, up 17% year-on-year Revenue in China was $3.691 billion, up 37% year-on-year China's revenue accounts for about 20% of the world's total, which is at a high level among the major MNCs Novo Nordisk Novo Nordisk's history dates back more than 80 years to a trip to the United States by a Danish couple, August Krogh, and his wife, Marie Krogh It was this trip that helped them learn about Canadian scientists treating diabetes with insulin extracted from the bovine pancreas, and obtained a license to produce insulin in Denmark, which also led to the birth of two insulin manufacturers, Nord and Noand In the 65 years since then, "Nord" and "No and" have both become pioneers in this field In 1989, Nord and Novo decided to merge and restructure and set up Novo Nordisk Now, both in China and globally, Novo Nordisk is a leader in diabetes Takeda, takeda,' also came from the name of the founder In 1781, Chobei Takeda, 32, opened a pharmacy in Osaka and began a distribution business of Japanese and traditional Chinese medicines After the Meiji Restoration, the Japanese market was opened, and the Takeda family gradually turned their targets to Western medicine In 1871, Takeda LED the then drug retailer son-in-arms in Yokohama to start importing and selling Western medicine, and around 1895, Takeda began importing drugs directly from the United Kingdom, the United States, Germany, Spain and other countries, and in 1907 won exclusive sales rights of Bayer products in Japan In the 100 years since Takeda opened the pharmacy, the family business was a distribution business until 1895, when Takeda acquired Uchibayashi Drug Works and built its own factory, which opened take-field's pharmaceutical path In recent decades, Takeda has made it possible to become the first Asian drugmaker to enter the global TOP10 in 2019 through global acquisitions and continued heavy investment in research and development TEVA the global generic drug giant originated in Jerusalem in 1901, not a pharmaceutical company, but a drug-inversion, not named Teva, but Boliai Pharmaceuticals This refers to the three Jewish pharmacists in Jerusalem, Bohna, Levin and Elstin, who poured all their savings into the pharmaceutical company in Jerusalem They organized the supply of medicines from Jerusalem, then used camels and donkeys as transportation tools, and shipped goods in batches to Palestinian areas for sale, and soon became one of the main local suppliers of medicines During World War II, Bole Ai Pharmaceuticals ushered in a new opportunity - in the 1930s Palestine became a high-density area of new Jews, including the scientific elite and even pharmaceutical talent, Elsa and Kurt, as the representatives Elsa and Kurt tied the fate of The Boliai Pharmaceuticals in Jerusalem in 1935 Based on the company originally established by Bohna, Levin and Elstin, they established a drug production base in Palestine with mutual funds and named it Teva Pharmaceuticals, in which "Teva" means Hebrew and means "nature" Since then, Teva Pharmaceuticals has fully equipped with the conditions and capabilities of self-marketing, they no longer single from Jerusalem, the service is no longer limited to the high Jewish dense Palestinian areas, but step by step outward "snowball" Boehringer Ingelheim Bollinger Ingelheim was founded in 1885 by Mr Albert Boehringer, initially with only 20 employees, and produced ligitic acid in a small factory in Ingerheim BI is still a family-owned company that entered China through its offices in 1994 BI is currently one of the world's top 20 pharmaceutical companies, with three main areas of human medicine, animal health and biopharmaceutical contract production.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.